CEO Roche Buys 9,000 Shares at 50% Discount, Sells 28,000 Shares in Same Window at Market‑Price – Hanover Insurance Taps Rule‑Based Insider Trading for Confidence Boost

Insider Activity at Hanover Insurance Group: A Closer Look at CEO Roche John C’s Recent Trades

The latest Form 4 from Hanover Insurance Group (THG) shows President and CEO John C. Roche buying 9,098 shares of common stock on May 19, 2026, as part of a Rule 10b5‑1 trading plan adopted on November 19, 2025. The purchase was executed at an average price of $85.87—well below the current market price of $194.56—implying that Roche was buying a large block of shares that were already vested under the plan. The same day, Roche also sold 24,766 shares at an average price of $193.79, and on May 20 he sold an additional 3,152 shares at $193.21 and 5,145 shares at $194.05. In total, Roche’s activity during this window resulted in a net purchase of roughly 3,000 shares, indicating a net long position that is still modest relative to his overall holdings but notable given the timing.

Implications for Investors

The fact that Roche is buying shares from the same trading plan that also generated the bulk of his sales suggests a disciplined, rule‑based approach rather than opportunistic trading. For investors, this can be a reassuring sign: the CEO is aligning his interests with shareholders by investing in the company’s stock when the plan permits. The net purchase of about 3,000 shares at a price more than 50 % below market value reflects the inherent value of the plan’s vesting schedule, but it also means that Roche is not exposing the company to large, market‑moving trades. The broader insider activity at THG is relatively quiet—aside from a handful of executive vice presidents making a handful of buys and sells—so Roche’s actions stand out as the most significant individual trade.

What This Means for THG’s Future

The company’s fundamentals remain solid: a market cap of $6.78 billion, a PE ratio of 9.81, and a 52‑week range that has recently approached the all‑time high of $199.59. Roche’s purchase aligns with a strategic narrative that the company is well‑positioned for steady growth in its core property‑and‑casualty lines. The timing—just before the 52‑week high—could signal confidence that the stock will continue to move upward, or at least stay within a healthy valuation band. However, the absence of any large, immediate gains or losses from the sale portion of the trade indicates that Roche is not reacting to short‑term market swings. For investors, the takeaway is that THG’s leadership remains aligned with long‑term value creation rather than short‑term speculation.

A Profile of Roche John C.

Roche’s insider history shows a pattern of periodic purchases and sales that are largely rule‑based. Over the past year he has exercised options in a 10b5‑1 plan (notably on May 18, 2026, when he exercised 375 shares at $196.55) and has sold large blocks when the plan allows. In the first quarter of 2026, he bought 152 shares at no cost (option vesting) and sold 14,220 shares at $180.63 on Feb 27, 2026. More recently, the May 19 buy and May 20 sells illustrate a consistent strategy of buying at lower exercise prices and selling when market prices are favorable, but always within the constraints of his trading plan. This disciplined approach has kept Roche’s holdings relatively stable—hovering around 140,000–160,000 shares—while avoiding any signals of insider pessimism or bullish speculation. In short, Roche’s trading record points to a long‑term, confidence‑building stance toward THG’s prospects.

Conclusion

For shareholders, Roche John C’s latest transactions suggest a steady, rule‑driven engagement with THG’s stock, reinforcing the alignment of executive interests with those of the broader investor base. The company’s strong fundamentals and the CEO’s disciplined trading pattern bode well for the near‑term outlook. While the current trade is modest in scale, it exemplifies the broader trend of executives using pre‑established trading plans to manage their positions without exposing the market to large, unplanned swings—a practice that can enhance confidence among institutional and retail investors alike.